Clinical and Life Sciences · 29 September 2026 to 29 September 2026 · 1 headlines · STAT
STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
England will cover an AstraZeneca breast cancer drug, a move resulting from a U.K.-U.S. drug pricing deal.
As it ran
29 September 2026
- STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal STAT
More from US healthcare
- STAT Plus: The last ‘breakthrough’ devices to get special treatment from Medicare 29 September 2026
- STAT Plus: 5 burning questions on Trump’s latest deals with drugmakers 29 September 2026
- Vaccine and drug policy in the midterm elections 29 September 2026
- STAT Plus: What to expect from UniQure’s upcoming Huntington’s gene therapy readout 29 September 2026
- The Illegal Drug Marketplace in Your Patients’ Pockets 29 September 2026
- 15M Americans live in a county with no general surgeons: study 28 September 2026
- Few Lab Tests Actually Need 8 Hours of Fasting, Study Suggests 28 September 2026
- First New Drug Approved for Idiopathic Nephrotic Syndrome in 70 Years 28 September 2026